BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 19337139)

  • 1. Rejection and acceptance of corneal allografts.
    Klebe S; Coster DJ; Williams KA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
    Coster DJ; Williams KA
    Am J Ophthalmol; 2005 Dec; 140(6):1112-22. PubMed ID: 16376660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulation in corneal transplantation.
    Fu H; Larkin DF; George AJ
    Transplant Rev (Orlando); 2008 Apr; 22(2):105-15. PubMed ID: 18631863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.
    Tavandzi U; Procházka R; Usvald D; Hlucílová J; Vitásková M; Motlík J; Vítová A; Filipec M; Forrester JV; Holán V
    Transplantation; 2007 May; 83(10):1401-3. PubMed ID: 17519795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W; Gao H; Xie L; Wang S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
    Dong Y; Huang YF; Wang LQ; Chen B
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
    Pillai RG; Beutelspacher SC; Larkin DF; George AJ
    Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the outcome of corneal transplantation.
    Coster DJ
    Ann R Coll Surg Engl; 1981 Mar; 63(2):91-7. PubMed ID: 6166235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunobiology of corneal transplantation.
    Williams KA; Coster DJ
    Transplantation; 2007 Oct; 84(7):806-13. PubMed ID: 17984831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of FK 506 eye drops following corneal transplantation].
    Reis A; Mayweg S; Birnbaum F; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):57-61. PubMed ID: 18236371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
    Shi WY; Liu T; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical FK-506 prevents experimental corneal allograft rejection.
    Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
    Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of corneal allograft rejection and regional immunosuppression.
    Coster DJ; Jessup CF; Williams KA
    Eye (Lond); 2009 Oct; 23(10):1894-7. PubMed ID: 19229274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
    Lunsford KE; Barbas AS; Brennan TV
    Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.
    Tabbara KF
    Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.